Anti-MAVS antibody [ABM28C8]
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(2 Publications)
Mouse Monoclonal MAVS antibody. Suitable for WB and reacts with Human samples. Cited in 2 publications. Immunogen corresponding to Recombinant Fragment Protein within Human MAVS aa 50-300.
View Alternative Names
IPS1, KIAA1271, VISA, MAVS, Mitochondrial antiviral-signaling protein, CARD adapter inducing interferon beta, Interferon beta promoter stimulator protein 1, Putative NF-kappa-B-activating protein 031N, Virus-induced-signaling adapter, Cardif, IPS-1
- WB
Lab
Western blot - Anti-MAVS antibody [ABM28C8] (AB220170)
False colour image of Western blot : Anti-MAVS antibody [ABM28C8] staining at 2 ug/ml, shown in green; Rabbit Anti-GAPDH antibody [EPR16891] (ab181602) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab220170 was shown to bind specifically to MAVS. A band was observed at 70 kDa in wild-type A549 cell lysates with no signal observed at this size in Mavs knockout cell line ab282354 (knockout cell lysate ab283026). To generate this image, wild-type and Mavs knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5% milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Mouse IgG H&L (IRDye® 800CW) preabsorbed (ab216772) and Goat anti-Rabbit IgG H&L (IRDye® 680RD) preabsorbed (ab216777) at 1/20000 dilution.
All lanes:
Western blot - Anti-MAVS antibody [ABM28C8] (ab220170) at 2 µg/mL
Lane 1:
Wild-type A549 cell lysate at 20 µg
Lane 2:
Mavs knockout A549 cell lysate at 20 µg
Lane 2:
Western blot - Human MAVS knockout A549 cell line (<a href='/en-us/products/cell-lines/human-mavs-knockout-a549-cell-line-ab282354'>ab282354</a>)
Lane 2:
Western blot - Human MAVS knockout A549 cell lysate (<a href='/en-us/products/cell-lysates/human-mavs-knockout-a549-cell-lysate-ab283026'>ab283026</a>)
Predicted band size: 57 kDa
Observed band size: 70 kDa
false
- WB
Supplier Data
Western blot - Anti-MAVS antibody [ABM28C8] (AB220170)
All lanes:
Western blot - Anti-MAVS antibody [ABM28C8] (ab220170) at 2 µg/mL
Lane 1:
Panc-28 cell lysate
Lane 2:
HCT116 cell lysate
Predicted band size: 57 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The MAVS protein activates important signaling cascades to produce type I interferons and other cytokines which are essential in the antiviral response. MAVS forms a complex with other proteins on the mitochondrial membrane helping to coordinate a rapid immune reaction to viral pathogens. It acts by amplifying the signal from RIG-I and MDA5 facilitating their role in the recognition of viral RNA. By recruiting downstream signaling molecules MAVS enables the activation of transcription factors like IRF3 and NF-kB.
Pathways
MAVS plays a central role in the signaling pathways that regulate innate immunity including the RIG-I-like receptor signaling pathway and the NF-kB pathway. It interacts with various proteins such as TRIF and STING in the pathways to modulate immune responses. These pathways help trigger the production of antiviral substances and maintain homeostasis within the body's defense mechanisms. MAVS provides a platform for the assembly of signaling complexes which are necessary for the propagation and amplification of the immune response signal.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Human genomics 17:93 PubMed37833774
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 11:453 PubMed32532953
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com